Overview
- 15 inspections across 15 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-01.
At a glance
Inspections
15
Sites
15
Observations
0
Career since
Jul 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lambda Therapeutic Research Ltd. | 1 May 2026 | Human Drugs | |
| Sitec Labs Limited | 23 Apr 2026 | Human Drugs | On file |
| QPS, LLC | 30 Jan 2026 | Human Drugs | On file |
| Aizant Drug Research Solutions Private Ltd. | 14 Nov 2025 | Human Drugs | On file |
| Vimta Labs Limited | 7 Nov 2025 | Human Drugs | On file |
Sites inspected
Lambda Therapeutic Research Ltd.Ahmedabad, India1 insp.
Sitec Labs LimitedNavi Mumbai, India1 insp.
QPS, LLCNewark, United States1 insp.
Aizant Drug Research Solutions Private Ltd.Hyderabad, India1 insp.
Vimta Labs LimitedHyderabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Kara A Scheibner4 shared
Kent A Conforti1 shared
Full investigator report
Get the verbatim findings behind Sylvestre K Dossou's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site